-
-
-
-
-
-
-
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
-
-
-
-
-
-
-
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
-
-
-
-
-
-
-
TransMedics gets FDA approval to start heart preservation trial
-
-
-
-
-
-
-
TD Cowen's Best Smidcap Ideas 2025
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against TransMedics Group, Inc. (TMDX)
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Files Securities Class Action AgainstĀ TransMedics Group, Inc. (NASDAQ: TMDX)
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Continued Investigation Into TransMedics Group, Inc. (TMDX)
-
1,208,067 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

